Stem Cell Tourism: Hope, Harm, and the Clinics in Between
Why unproven stem cell treatments remain a serious global health problem
This post is for informational purposes only and does not constitute medical advice. If you are considering any stem cell treatment, consult with a qualified healthcare provider before making any decisions.
Stem cell research is one of the most promising areas in modern medicine. Stem cells can, under the right conditions, develop into many different cell types — muscle, nerve, heart tissue — and this has made them an object of enormous scientific interest for treating diseases that currently have no cure.
It has also made them an object of exploitation.
Around the world, hundreds of clinics offer stem cell treatments for conditions ranging from Parkinson’s disease and multiple sclerosis to autism and spinal cord injury. Many of these treatments are unproven. Most are unregulated. Patients — often desperate, often seriously ill — pay tens of thousands of dollars for procedures that have never been tested in rigorous clinical trials.
This is stem cell tourism. And it is causing real harm.
What Stem Cell Tourism Is
The term refers to patients traveling — sometimes across the world — to receive stem cell treatments that are not approved or available in their home country.
The reasons are understandable. Serious illness creates urgency. Conventional medicine does not always have answers. When a clinic promises results that established medicine cannot offer, the appeal is obvious — especially when patients or their families are watching a condition deteriorate and feel they are running out of time.
But the gap between what legitimate stem cell science can currently deliver and what many of these clinics claim is vast. And the consequences of crossing that gap can be severe.
The Risks Are Real
Without regulatory oversight and rigorous clinical testing, the risks of unproven stem cell treatments are significant and poorly understood.
Stem cells administered in uncontrolled settings can cause infections, immune reactions, and in some cases tumor formation — because cells that proliferate extensively are not always easy to control once inside the body. There have been documented cases of patients developing growths at injection sites, of severe immune responses, and of permanent disability following procedures at unregulated clinics.
One widely reported case involved patients at a Florida clinic who paid up to $20,000 to have stem cells injected into their eyes as part of an unregulated trial. Several lost significant vision as a result. In 2019, the FDA shut down another Florida clinic offering stem cell treatments for a broad range of conditions — a pattern that reflects how difficult these clinics are to regulate, and how quickly new ones appear.
Beyond the physical risks, the financial cost is substantial. These treatments are almost never covered by insurance. Patients pay out of pocket, often for procedures that have no evidence of benefit — and occasionally for procedures that make their condition worse.
Why Regulation Exists
Regulatory approval — by bodies such as the FDA in the United States or the EMA in Europe — is not a bureaucratic obstacle. It is the result of a process designed to establish, through controlled clinical trials, whether a treatment is safe and whether it actually works.
That process is slow and expensive. It is also how medicine learned that many treatments that seemed promising in early studies failed in larger ones, and how harms that were not visible in small trials became apparent at scale.
Stem cell science is genuinely promising. Several stem cell therapies have gone through this process and are now approved and in clinical use — bone marrow transplantation for blood cancers being the most established example. The science itself is not the problem. The problem is clinics that skip the process entirely and sell hope in its place.
The ISSCR Guidelines
The International Society for Stem Cell Research (ISSCR) is the leading professional organization for stem cell scientists globally. It has published detailed guidelines for stem cell research and its translation into clinical therapies — a framework intended to ensure that the field develops responsibly.
The guidelines cover several key areas. They set standards for the scientific and ethical conduct of stem cell research. They establish criteria that must be met before experimental stem cell treatments are offered to patients, including requirements for preclinical evidence, independent oversight, and informed consent. They also explicitly address the problem of unproven treatments, advising strongly against stem cell interventions that have not gone through appropriate clinical evaluation.
For patients navigating this landscape, the ISSCR website provides a patient handbook and a tool for evaluating specific clinics and claims. It is one of the more practical resources available for anyone trying to distinguish legitimate research from commercial exploitation.
How to Recognize a Problematic Clinic
Not every clinic offering stem cell treatments is operating in bad faith, but certain patterns are consistent warning signs.
Claims that a single stem cell therapy can treat many unrelated diseases should be treated with skepticism. Stem cell biology is specific — different conditions involve different cell types and mechanisms, and broad claims rarely reflect genuine scientific understanding.
The absence of peer-reviewed published evidence is another warning sign. Legitimate treatments are tested and the results published in scientific journals where other researchers can evaluate them. If a clinic cannot point to this evidence, there is a reason.
Pressure to decide quickly, large upfront fees, and promises of results that established medicine has not been able to achieve are further indicators that caution is warranted.
The most important step is straightforward: consult with a physician who is not affiliated with the clinic before committing to any treatment. A second opinion from a specialist in the relevant condition is always worth seeking.
The Broader Problem
Stem cell tourism persists because it sits at the intersection of genuine scientific promise, serious unmet medical need, and inadequate international regulation.
The science gives clinics credibility they have not earned. The desperation of patients makes them vulnerable to that credibility. And because clinics can operate across jurisdictions, regulation in one country does not prevent patients from traveling to another.
For the field of stem cell research itself, this is damaging. Every patient harmed by an unproven treatment, every family that spends their savings on something that does not work, makes it harder to build the public trust that legitimate research depends on.
The treatments that will eventually come from stem cell science — and some will — will have been earned through years of careful, incremental work. That work is ongoing. It does not need to be rushed by clinics selling shortcuts.
Background and Further Reading
International Society for Stem Cell Research. ISSCR Guidelines for Stem Cell Research and Clinical Translation. 2021. isscr.org
Cyranoski D. The global race to develop stem cell treatments. Nature. 2013.
Turner L., Knoepfler P. Selling stem cells in the USA: assessing the direct-to-consumer industry. Cell Stem Cell. 2016.
Marks P. et al. Clarifying stem-cell-based product regulation. New England Journal of Medicine. 2017.
Pew Charitable Trusts. Unapproved stem cell interventions: risks and the need for greater FDA enforcement. 2019.